The MAPK Pathway Signals Telomerase Modulation in Response to Isothiocyanate-Induced DNA Damage of Human Liver Cancer Cells

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Lamy, Evelyn ^a   Herz, Corinna ^a   Lutz Bonengel, Sabine ^a   Hertrampf, Anke ^a,b   Márton, Melinda Rita ^a,c   Mersch Sundermann, Volker ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ERUCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN; TELOMERASE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL AGING; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CANCER; OXIDATIVE STRESS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; DNA DAMAGE; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOTHIOCYANATES; LIVER NEOPLASMS; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TELOMERASE;

EID: 84873182162     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053240     Document Type: Article

References (55)

1. Shay JW, Bacchetti S, (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791.
2. Zhang P, Chan S, Fu W, Mendoza M, Mattson M, (2003) TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability. FASEB J 17: 767-769.
3. Akiyama M, Yamada O, Kanda N, Akita S, Kawano T, et al. (2002) Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors. Cancer Lett 178: 187-197.
4. Massard C, Zermati Y, Pauleau A, Larochette N, Métivier D, et al. (2006) hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway. Oncogene 25: 4505-4514.
5. Xi L, Chen G, Zhou J, Xu G, Wang S, et al. (2006) Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway. Apoptosis 11: 789-798.
6. Hecht SS, (1999) Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. J Nutr 129: 768S-774S.
7. Conaway CC, Yang YM, Chung FL, (2002) Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr Drug Metab 3: 233-255.
8. Bianchini F, Vainio H, (2004) Isothiocyanates in cancer prevention. Drug Metab Rev 36: 655-667.
9. Keum YS, Jeong WS, Kong AN, (2004) Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms. Mutat Res 555: 191-202.
10. Clarke JD, Riedl K, Bella D, Schwartz SJ, Stevens JF, et al. (2011) Comparison of isothiocyanate metabolite levels and histone deacetylase activity in human subjects consuming broccoli sprouts or broccoli supplement. J Agric Food Chem 59: 10955-10963.
11. Meeran SM, Patel SN, Tollefsbol TO, (2010) Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One 5: e11457.
12. Moon DO, Kang SH, Kim KC, Kim MO, Choi YH, et al. (2010) Sulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathway. Cancer Lett 295: 260-266.
13. Mukherjee S, Bhattacharya RK, Roy M, (2009) Targeting protein kinase C (PKC) and telomerase by phenethyl isothiocyanate (PEITC) sensitizes PC-3 cells towards chemotherapeutic drug-induced apoptosis. J Environ Pathol Toxicol Oncol 28: 269-282.
14. Mukherjee S, Dey S, Bhattacharya RK, Roy M, (2009) Isothiocyanates sensitize the effect of chemotherapeutic drugs via modulation of protein kinase C and telomerase in cervical cancer cells. Mol Cell Biochem 330: 9-22.
15. Nakamura Y, (2009) Chemoprevention by isothiocyanates: molecular basis of apoptosis induction. Forum Nutr 61: 170-181.
16. Lamy E, Mersch-Sundermann V, (2009) MTBITC mediates cell cycle arrest and apoptosis induction in human HepG2 cells despite its rapid degradation kinetics in the in vitro model. Environ Mol Mutagen 50: 190-200.
17. Lamy E, Crossmann C, Saeed A, Schreiner PR, Kotke M, et al. (2009) Three structurally homologous isothiocyanates exert "Janus" characteristics in human HepG2 cells. Environ Mol Mutagen 50: 164-170.
18. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J, (1982) Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42: 3858-3863.
19. Guguen-Guillouzo C, Bourel M, Guillouzo A, (1986) Human hepatocyte cultures. Prog Liver Dis 8: 33-50.
20. Strom S, Michalopoulos G, (1982) Mutagenesis and DNA binding of benzo(a)pyrene in cocultures of rat hepatocytes and human fibroblasts. Cancer Res 42: 4519-4524.
21. Lamy E, Kassie F, Gminski R, Schmeiser HH, Mersch-Sundermann V, (2004) 3-Nitrobenzanthrone (3-NBA) induced micronucleus formation and DNA damage in human hepatoma (HepG2) cells. Toxicol Lett 146: 103-109.
22. Burnette WN, (1981) "Western blotting".: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112: 195-203.
23. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
24. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
25. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
26. Wagner EF, Nebreda AR, (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-549.
27. Wu X, Zhou QH, Xu K, (2009) Are isothiocyanates potential anti-cancer drugs? Acta Pharmacol Sin 30: 501-512.
28. Hsin IL, Sheu GT, Chen HH, Chiu LY, Wang HD,et al. N-acetyl cysteine mitigates curcumin-mediated telomerase inhibition through rescuing of Sp1 reduction in A549 cells. Mutat Res 688: 72-77.
29. Min NY, Kim JH, Choi JH, Liang W, Ko YJ, et al. (2012) Selective death of cancer cells by preferential induction of reactive oxygen species in response to (-)-epigallocatechin-3-gallate. Biochem Biophys Res Commun 421: 91-97.
30. Jakubowski W, Bartosz G, (2000) 2,7-dichlorofluorescin oxidation and reactive oxygen species: what does it measure? Cell Biol Int 24: 757-760.
31. Pizzimenti S, Briatore F, Laurora S, Toaldo C, Maggio M, et al. (2006) 4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines. Free Radic Biol Med 40: 1578-1591.
32. Pizzimenti S, Menegatti E, Berardi D, Toaldo C, Pettazzoni P, et al. (2010) 4-hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity. J Nutr Biochem 21: 818-826.
33. Van Houten B, Woshner V, Santos JH, (2006) Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair (Amst) 5: 145-152.
34. Shammas MA, Koley H, Batchu RB, Bertheau RC, Protopopov A, et al. (2005) Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential. Mol Cancer 4: 24.
35. Zanichelli F, Capasso S, Cipollaro M, Pagnotta E, Carteni M, et al. (2012) Dose-dependent effects of R-sulforaphane isothiocyanate on the biology of human mesenchymal stem cells, at dietary amounts, it promotes cell proliferation and reduces senescence and apoptosis, while at anti-cancer drug doses, it has a cytotoxic effect. Age (Dordr) 34: 281-293.
36. Zanichelli F, Capasso S, Di Bernardo G, Cipollaro M, Pagnotta E, et al. (2012) Low concentrations of isothiocyanates protect mesenchymal stem cells from oxidative injuries, while high concentrations exacerbate DNA damage. Apoptosis 17: 964-974.
37. Wada T, Penninger JM, (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23: 2838-2849.
38. Alfonso-De Matte MY, Yang H, Evans MS, Cheng JQ, Kruk PA, (2002) Telomerase is regulated by c-Jun NH2-terminal kinase in ovarian surface epithelial cells. Cancer Res 62: 4575-4578.
39. Potapova O, Basu S, Mercola D, Holbrook NJ, (2001) Protective role for c-Jun in the cellular response to DNA damage. J Biol Chem 276: 28546-28553.
40. Li H, Liu JP, (2007) Mechanisms of action of TGF-beta in cancer: evidence for Smad3 as a repressor of the hTERT gene. Ann N Y Acad Sci 1114: 56-68.
41. Li H, Xu D, Li J, Berndt MC, Liu JP, (2006) Transforming growth factor beta suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene. J Biol Chem 281: 25588-25600.
42. Lacerte A, Korah J, Roy M, Yang XJ, Lemay S, et al. (2008) Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors. Cell Signal 20: 50-59.
43. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, et al. (1999) Direct activation of TERT transcription by c-MYC. Nat Genet 21: 220-224.
44. Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, et al. (1999) Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18: 1219-1226.
45. Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, et al. (2000) Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 28: 669-677.
46. Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, et al. (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 59: 551-557.
47. Takakura M, Kyo S, Inoue M, Wright WE, Shay JW, (2005) Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells. Mol Cell Biol 25: 8037-8043.
48. Gunes C, Lichtsteiner S, Vasserot AP, Englert C, (2000) Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res 60: 2116-2121.
49. Masutomi K, Possemato R, Wong JM, Currier JL, Tothova Z, et al. (2005) The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci U S A 102: 8222-8227.
50. Torres M, Forman HJ, (2003) Redox signaling and the MAP kinase pathways. Biofactors 17: 287-296.
51. Antosiewicz J, Ziolkowski W, Kar S, Powolny AA, Singh SV, (2008) Role of reactive oxygen intermediates in cellular responses to dietary cancer chemopreventive agents. Planta Med 74: 1570-1579.
52. Rose P, Whiteman M, Huang SH, Halliwell B, Ong CN, (2003) beta-Phenylethyl isothiocyanate-mediated apoptosis in hepatoma HepG2 cells. Cell Mol Life Sci 60: 1489-1503.
53. Klapper W, Qian W, Schulte C, Parwaresch R, (2003) DNA damage transiently increases TRF2 mRNA expression and telomerase activity. Leukemia 17: 2007-2015.
54. Moriarty TJ, Dupuis S, Autexier C, (2002) Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide. Leukemia 16: 1112-1120.
55. Sato N, Mizumoto K, Kusumoto M, Nishio S, Maehara N, et al. (2000) Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide. Br J Cancer 82: 1819-1826.